Speaker Profile

Ph.D., CTO and Co-Founder, Day Zero Diagnostics

Biography
Miriam Huntley leads the machine learning and genome sequencing work at the company. Prior to founding DZD, Miriam earned her PhD in Applied Math at Harvard University and her BSc. from MIT in Physics. For her PhD she developed quantitative methods for problems in biology, and her work discovered fundamental structures in the three-dimensional folded genome. Her academic work has been widely cited and covered in the public media by outlets such as NPR and Forbes, and exhibited at the Smithsonian Museum.


Clinical Dx Showcase:
Day Zero Diagnostics

Day Zero Diagnostics is an infectious disease diagnostics company using whole-genome sequencing and machine learning to combat the rise of antibiotic-resistant infections.

Definitive Determination of Clonality in Hospital-acquired Infections
Introducing epiXact, a rapid WGS-based service that provides hospitals with definitive and accurate answers for infection transmission investigations. epiXact computes pathogen relatedness at the single nucleotide level using a high-resolution SNP based pipeline enabling the highest confidence in clonality determination.

 Session Abstract – PMWC 2022 Silicon Valley


The PMWC 2022 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.

- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Nerodegenerative